In agreement, tumor infiltrating regulatory T cells (which release high amounts of TGFβ in the TME) improve survival in cancers with a long pre-metastatic periods like lymphoma, but have a negative effect on survival in cancers with an early immune evasion like breast cancer, lung cancer, or aggressive squamous cell carcinoma (2). Here, TGFB1 is linked to lung carcinoma.